Jean H. Hoffman-Censits

机构：Bloomberg (United States), Johns Hopkins University, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, University of Baltimore · ORCID：0000-0002-6970-6509

发表论文 334 篇 · 总被引 15868 次 · h-index 37

代表论文

• IK-175, an Oral Aryl Hydrocarbon Receptor Inhibitor, Alone and with Nivolumab in Patients with Advanced Solid Tumors and Urothelial Carcinoma (2025 · Clinical Cancer Research · 被引 6)
• Enfortumab vedotin plus pembrolizumab (EV+P) vs chemotherapy for previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC): 3.5-year follow-up and response analyses from the phase 3 EV-302 study. (2026 · Journal of Clinical Oncology · 被引 2)
• Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma (2025 · European Urology · 被引 1)
• Supplemental Figure 9 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors (2026)
• Supplemental Table 6 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors (2026)
• Supplemental Figure 13 from Peripheral Th17 Immune Signature Associates with Excellent Response to Anti–PD-1/Anti–PD-L1 Therapy across Solid Tumors (2026)